Primary completion date changed
Before: Jul 2026. After: Dec 2026.
Recruitment status changed
Before: Recruiting. After: Active not recruiting.
Study sponsor: Dogwood Therapeutics Inc. · DWTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: Jul 2026. After: Dec 2026.
Before: Recruiting. After: Active not recruiting.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: To explore the efficacy of Halneuron in the treatment of patients with Chemotherapy-Induced Neuropathic Pain Measure: To explore the Safety of Halneuron in the treatment of patients with Chemotherapy-Induced Neuropathic Pain. After: Measure: NRS Pain Measure: Safety Assessments.
Before: 200 participants (planned). After: 240 participants (planned).